During the first five months of this year, EIPICO pharmaceuticals company achieved sales growth of 19.9%, which representing 3.8% of the Egyptian pharmaceutical market.
The latest report of the international pharmaceutical information organization (IMS) revealed that EIPICO sales increased to be 1.186 billion L.E- for the period of January to May 2019 compared with 989.572 million L.E. achieved for the same period of 2018. Keeping the fifth place among the best-selling pharmaceutical companies in Egypt July 8th, 2019 .
July 8th, 2019